We are live on ! Find out more
NPT

National Philanthropic Trust Portfolio holdings

AUM $6.92B
1-Year Est. Return 24.7%
This Fund
S&P 500
This Quarter Est. Return
+14.05%
1 Year Est. Return
+24.7%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$5.24B
AUM Growth
+$663M
Cap. Flow
+$126M
Cap. Flow %
2.4%
Top 10 Hldgs %
72.72%
Holding
280
New
11
Increased
45
Reduced
82
Closed
22

Top Buys

Rank Stock Value
1
APO icon
Apollo Global Management
APO
+$134M
2
AVGO icon
Broadcom
AVGO
+$46.2M
3
TSM icon
TSMC
TSM
+$20.8M
4
VOO icon
Vanguard S&P 500 ETF
VOO
+$12.6M
5
PRGO icon
Perrigo
PRGO
+$5.64M

Sector Composition

Rank Sector Weight
1 Technology 35.98%
2 Miscellaneous 27.36%
3 Financials 25.95%
4 Consumer Discretionary 4.3%
5 Communication Services 3.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CSCO icon
226
Cisco
CSCO
$422B
$270K 0.01%
5,679
-1,834
-24% -$87.1K
AZN icon
227
AstraZeneca
AZN
$255B
$260K 0.01%
1,665
-519
-24% -$78.1K
BUR icon
228
Burford Capital
BUR
$856M
$249K ﹤0.01%
+19,098
New +$280K
SIL icon
229
Global X Silver Miners ETF NEW
SIL
$4.54B
$246K ﹤0.01%
7,884
– –
CFR icon
230
Cullen/Frost Bankers
CFR
$9.58B
$245K ﹤0.01%
2,415
+23
+1% +$2.41K
FCG icon
231
First Trust Natural Gas ETF
FCG
$651M
$231K ﹤0.01%
8,792
– –
DSMC icon
232
Distillate Small/Mid Cash Flow ETF
DSMC
$138M
$226K ﹤0.01%
6,500
– –
BAC icon
233
Bank of America
BAC
$384B
$223K ﹤0.01%
5,601
-2,641
-32% -$101K
PPLT
234
abrdn Physical Platinum Shares ETF
PPLT
$2.07B
$213K ﹤0.01%
+23,310
New +$210K
REGN icon
235
Regeneron Pharmaceuticals
REGN
$77.3B
$211K ﹤0.01%
+201
New +$195K
ERTH icon
236
Invesco MSCI Sustainable Future ETF
ERTH
$123M
$211K ﹤0.01%
+5,341
New +$220K
ETN icon
237
Eaton
ETN
$168B
$205K ﹤0.01%
654
-69
-10% -$22.3K
ZM icon
238
Zoom
ZM
$25.8B
$203K ﹤0.01%
3,422
– –
DES icon
239
WisdomTree US SmallCap Dividend Fund
DES
$2.05B
$202K ﹤0.01%
6,500
– –
TLS icon
240
Telos
TLS
$302M
$201K ﹤0.01%
50,000
– –
BRAG
241
Bragg Gaming Group
BRAG
$39.1M
$192K ﹤0.01%
33,262
– –
RXRX icon
242
Recursion Pharmaceuticals
RXRX
$2.16B
$188K ﹤0.01%
25,000
– –
BTX
243
BlackRock Technology and Private Equity Term Trust
BTX
$1.04B
$181K ﹤0.01%
25,000
– –
AMPY icon
244
Amplify Energy
AMPY
$172M
$177K ﹤0.01%
26,126
– –
ZLAB icon
245
Zai Lab
ZLAB
$2.91B
$173K ﹤0.01%
10,000
– –
ICLN icon
246
iShares Global Clean Energy ETF
ICLN
$2.21B
$140K ﹤0.01%
+10,499
New +$147K
RKLB icon
247
Rocket Lab Corp
RKLB
$44.6B
$128K ﹤0.01%
26,699
– –
ABUS icon
248
Arbutus Biopharma
ABUS
$929M
$112K ﹤0.01%
36,211
– –
JMIA
249
Jumia Technologies
JMIA
$895M
$96K ﹤0.01%
13,681
– –
PDLB icon
250
Ponce Financial Group
PDLB
$484M
$92.3K ﹤0.01%
10,094
– –

Similar funds

National Philanthropic Trust's Q2 2024 Portfolio in Review

As of Q2 2024, National Philanthropic Trust held 280 positions worth $5.24B, up 14% from $4.58B the previous quarter. Its ten largest holdings account for 73% of the portfolio.

National Philanthropic Trust's Q2 2024 filing shows 11 new, 45 increased, 82 reduced and 22 closed positions. Its largest new stake was Avadel Pharmaceuticals: 219,296 shares worth $3.08M. The largest sale was NVIDIA, an estimated $52.6M.

By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 31% a quarter earlier, followed by Miscellaneous and Financials.

  • National Philanthropic Trust's largest Q2 2024 buy was Avadel Pharmaceuticals: 219,296 shares worth $3.08M.
  • National Philanthropic Trust added most to Apollo Global Management in Q2 2024, an estimated $134M increase.
  • National Philanthropic Trust's biggest Q2 2024 reduction was NVIDIA, cutting an estimated $52.6M.
  • National Philanthropic Trust fully exited United Parcel Service in Q2 2024, selling an estimated $5.12M.
  • National Philanthropic Trust's ten largest holdings make up 73% of its $5.24B portfolio in Q2 2024.
  • National Philanthropic Trust opened 11 new positions and closed 22 in Q2 2024.
  • National Philanthropic Trust's portfolio value rose 14% quarter-over-quarter to $5.24B.

Based on National Philanthropic Trust's 13F filing for Q2 2024, filed 15 May 2026.